<Dec 28, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short THRESHOLD list: Immunicon Corporation (NASDAQ: IMMC), Particle Drilling Technologies Inc. (NASDAQ: PDRT), New York Health Care (OTCBB: BBAL), Ceptor Corporation (OTCBB: CEPO), Fonix Corp New (OTCBB: FNIX), Universal Guardian Holdings, Inc. (OTCBB: UGHO). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.
Immunicon Corporation (NASDAQ: IMMC) engages in the development, manufacture, marketing, and sale of proprietary cell-based diagnostic and research products, and services with a focus on cancer. It develops technologies that identify, count, and characterize a small number of circulating tumor cells (CTC) and other rare cells present in a blood sample of a patient. The company offers CellSave Preservative Tube, an evacuated blood collection tube with preservative; CellTracks AutoPrep System, an automated instrument to capture and label cells from 7.5 ml blood samples; CellTracks MagNest Cell, a presentation device, which presents magnetically labeled cells for analysis; CellSpotter Analyzer; CellTracks Analyzer II, which is a semi-automated fluorescence microscope used to count and characterize cells; the CellSearch Circulating Tumor Cell Kit, which is used for counting CTCs in blood; CellSearch Profile Kit, which is used to isolate CTCs for subsequent molecular or cellular analysis; CellTracks Endothelial Cell Kit that is used in isolating and counting endothelial cells; CellTracks Bone Marrow Tumor Kit; Molecular diagnostic kits; and Tumor Phenotyping Reagents, which are research reagents for cell characterization. The company offers its products to hospitals, reference laboratories, clinical research organizations, and pharmaceutical/biotechnology companies in the United States, Europe, Japan, and Hong Kong. Immunicon has agreements with Veridex, LLC; KREATECH Biotechnology B.V.; Research and Diagnostic Systems, Inc.; and Pfizer, Inc. The company was founded in 1983 and is based in Huntingdon Valley, Pennsylvania. With 27.67 million shares outstanding and 1.07 million shares declared short as of November 2006, there is a failure to deliver in shares of IMMC.
. . .
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf . . . .>
>>Exactly what level of panic should we experience?<<
Mr. Brown, I wish I knew. I don't know enough about naked short selling. I do know it's illegal (and I believe zealous naked short sellers can bring down a company, move that company to the pink lists or worse), and I think we should all � every single long among us � write to, or phone, Immunicon's investor relations and ask them what, if any, defense they are mounting. I do not expect a satisfactory answer, but I do think they need to be put on notice that we are watching. The SEC has a known allergy to naked short selling.